(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate
97%
- Product Code: 113153
CAS:
1175536-50-1
| Molecular Weight: | 365.35 g./mol | Molecular Formula: | C₁₃H₁₇F₂N₃O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, stored under inert gas |
Product Description:
This compound is primarily utilized in the development of antifungal medications. It is effective in treating fungal infections by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes. This disruption leads to increased membrane permeability and eventual cell death, making it particularly effective against a range of fungal pathogens, including Candida species and Aspergillus. It is often formulated into oral tablets, intravenous solutions, or topical creams for targeted treatment. Additionally, its methanesulfonate salt form enhances solubility and bioavailability, improving its therapeutic efficacy. This chemical is also explored in research for potential applications in antifungal coatings for medical devices and materials to prevent fungal colonization.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Yellow Powder Or Crystals |
| Purity (%) | 96.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | Ft6,141.24 |
+
-
|
| 1.000 | 10-20 days | Ft14,006.34 |
+
-
|
| 5.000 | 10-20 days | Ft45,897.70 |
+
-
|
| 10.000 | 10-20 days | Ft83,822.56 |
+
-
|
(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol with methanesulfonate
This compound is primarily utilized in the development of antifungal medications. It is effective in treating fungal infections by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes. This disruption leads to increased membrane permeability and eventual cell death, making it particularly effective against a range of fungal pathogens, including Candida species and Aspergillus. It is often formulated into oral tablets, intravenous solutions, or topical creams for targeted treatment. Additionally, its methanesulfonate salt form enhances solubility and bioavailability, improving its therapeutic efficacy. This chemical is also explored in research for potential applications in antifungal coatings for medical devices and materials to prevent fungal colonization.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :